Ghent biotech company raises 100m dollars with new investors

Ghent biotech company Agomab, which develops treatments to restore connective tissue formation in organs, has raised 100 million dollars in a new series of investments, the company announced on Wednesday.

The new round of financing was led by US asset manager Fidelity. In addition to existing investors, including US pharmaceutical giant Pfizer, Agomab has also attracted new backers such as the European investment fund EQT Life Sciences, American venture capital firm Canaan and Dawn Biopharma of the American investment firm KKR.

Agomab will primarily use the funds to finance further clinical research with AGMB-129. This is a candidate for the treatment of bowel narrowing due to scarring in Crohn's disease. In 2022, the company will have successfully completed the first clinical research phase, and the US Food and Drug Administration will put the treatment through an accelerated approval process.

Agomab is also working on a treatment for pulmonary fibrosis (AGMB-447).


#FlandersNewsService | © PHOTO JEREMIE RICHARD / AFP

Related news

Website preview
Belgian biotech firms among European market leaders
Belgium has climbed to second place in the European biotech industry, after Denmark, according to data released by KBC Securities on Wednesday. At...
Website preview
Ghent University and VIB to develop vaccine technology against bacterial infections
Ghent University (UGent) and the Flemish Institute for Biotechnology (VIB) are leading a European network that has secured a grant of 8 million...

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.


Belga News Agency delivers dependable, rapid and high-quality information 24 hours a day, 7 days a week, from Belgium and abroad to all Belgian media. The information covers all sectors, from politics, economics and finance to social affairs, sports and culture, not to mention entertainment and lifestyle.

Every day, our journalists and press photographers produce hundreds of photos and news stories, dozens of online information items, plus audio and video bulletins, all in both national languages. Since the end of March 2022 English has been added as a language.

For public institutions, businesses and various organisations that need reliable information, Belga News Agency also offers a comprehensive range of corporate services to meet all their communication needs.


Arduinkaai 29 1000 Brussels